Top 50 Health Care Startup Investors in Ireland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
73 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$12M |
|
SOSV
VC Fund
|
24 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Western Development Commission
VC Fund
|
19 | Ireland, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $642k–$11M |
|
Irrus Investments
VC Fund
|
16 | Ireland, Sweden, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $713k–$8.8M |
|
Atlantic Bridge
VC Fund
|
14 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $4.5M–$62M |
|
HBAN
VC Fund
|
14 | Ireland, United Kingdom, United States | Seed, Series A | Health Care, Software, Medical Device | $625k–$8.8M |
|
Atlantic Bridge University Fund
VC Fund
|
13 | Ireland, United States | Seed, Series A, Series B | Medical Device, Health Care, Big Data | $823k–$80M |
|
Kernel Capital
VC Fund
|
13 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $531k–$9M |
|
AIB Seed Capital Fund
VC Fund
|
13 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $549k–$8.1M |
|
Elkstone Capital Partners
VC Fund
|
12 | Ireland, United Kingdom, United States | Seed, Series A | Software, Artificial Intelligence, Health Care | $610k–$20M |
|
HBAN Medtech Syndicate
VC Fund
|
10 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | $1.3M–$2.1M |
|
Furthr VC
VC Fund
|
10 | Ireland | Seed, Pre-Seed | Medical Device, Medical, Software | $878k–$3.9M |
|
Enterprise Equity
VC Fund
|
10 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Health Care | $549k–$7.5M |
|
NDRC
VC Fund
|
10 | Ireland, United States, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, Information Technology, E-Commerce | |
|
Act Venture Capital
VC Fund
|
10 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $823k–$13M |
|
Fountain Healthcare Partners
VC Fund
|
9 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
Seroba Life Sciences
VC Fund
|
8 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
EIT Health
VC Fund
|
7 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $22k–$1.6M |
|
Delta Partners
VC Fund
|
6 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $795k–$6.6M |
|
Ascentifi
VC Fund
|
6 | Ireland | Seed, Series A | Health Care, Medical Device, Medical | |
|
Business Venture Partners
VC Fund
|
6 | Ireland, Luxembourg, The Netherlands | Seed, Series A | Health Care, Information Technology, Medical | $658k–$12M |
|
EQT Life Sciences
VC Fund
|
5 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$165M |
|
The Yield Lab Europe
VC Fund
|
5 | Ireland, France, United Kingdom | Seed, Series A | AgTech, Agriculture, Biotechnology | $531k–$10M |
|
Boole
VC Fund
|
4 | Ireland | Seed | Health Care, Medical Device, Medical | $3.8M–$3.8M |
|
Xenium Capital
VC Fund
|
4 | Ireland | Seed | Medical Device, Health Care, Biotechnology | $2.5M–$3.8M |
|
Lightstone Ventures
VC Fund
|
4 | United States, Ireland, Singapore | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7M–$105M |
|
Business Growth Fund
VC Fund
|
4 | United Kingdom, Ireland, United States | Series A, Private Equity | Software, Information Technology, Health Care | |
|
Development Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Private Equity | Manufacturing, Telecommunications, VoIP | |
|
Broadview Ventures
VC Fund
|
3 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Medtech Syndicate Nominee
VC Fund
|
3 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
Faber
VC Fund
|
3 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $34k–$25M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
Boole Investment Syndicate
VC Fund
|
3 | Ireland, Estonia, United States | Seed, Series A | SaaS, Software, Biotechnology | $642k–$1.6M |
|
SVG Ventures
VC Fund
|
2 | United States, Canada, Ireland | Pre-Seed, Seed | AgTech, Agriculture, Farming | |
|
Growing Capital
VC Fund
|
2 | Ireland | Seed, Pre-Seed | Software, Analytics, Health Care | |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | |
|
CAJU Venture Partners
VC Fund
|
2 | Ireland | Health Care, Medical Device | ||
|
Linda Kiely
Angel
|
2 | Ireland | Seed, Series A | SaaS, Software, Analytics | $1M–$1.1M |
|
Dan Kiely
Angel
|
2 | Ireland | Seed, Series A | Software, Human Resources, Machine Learning | $240k–$1.2M |
|
Liam Casey
Angel
|
2 | Ireland, United Kingdom, Colombia | Seed, Pre-Seed, Angel | Software, E-Commerce, Information Technology | $800k–$7.2M |
|
John Purdy
Angel
|
2 | Ireland | Seed | Software, FinTech, Medical | $576k–$1.1M |
|
Gaingels
VC Fund
|
2 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.4M–$100M |
|
Life Sciences Fund Amsterdam
VC Fund
|
2 | Ireland, The Netherlands | Series A, Private Equity | Medical Device, Medical, Communities | |
|
Mayo Clinic Ventures
VC Fund
|
2 | United States, Ireland, China | Series A, Seed, Series B | Health Care, Biotechnology, Therapeutics | $1.4M–$69M |
|
Glanzmann Enterprises
VC Fund
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
|
Earlybird Venture Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.4M–$75M |
|
Gilde Healthcare
VC Fund
|
2 | United States, The Netherlands, Germany | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $8.8M–$120M |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.8M–$250M |
|
Frank Dolphin
Angel
|
2 | Ireland | Seed, Angel | Hospital, Health Care | |
| Access all 373 investors in Ireland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 506
- Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
- Pulsate — Pulsate enables direct communication with customers based on their location, context, interests and behaviours. Pulsate allows you to design and push rich media content directly to customers devices. Deepen the relationship by establishing a customer dialogue. Allow users to reply to your campaigns, provide feedback and keep complaints outside ofsocial media. Maximize foot traffic by targeting street level or competitor locations. Combine with segmentation for optimal results. iBeacons:tm: enable you to understand indoor customer location and context with incredible accuracy. Easily manage deployment and configuration of iBeacons:tm: with the Pulsate cloud platform. Gain a deeper understanding of your mobile customers and a comprehensive view of each mobile campaign.
- Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 43
- Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$3.8M; Series A $2.2M–$8.8M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
- Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 138
- Round size: Series A $4.5M–$26M; Series B $10M–$62M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- GloNav — GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellularhandset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.
- Elisity — Elisity Cognitive Trust delivers identity-based segmentation and least privilege access without the need to reconfigure networks and micromanage hardware.
- Luminate Medical — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 65
- Round size: Seed $625k–$3.5M; Series A $1.2M–$8.8M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Glitch Ads — Launch AI Powered Google Ad Campaigns in Minutes. Think of us like an agency in a box. Built for speed. Priced for scaling companies. Powered by AI.
- SeeMeHired — SeeMeHired is a cloud-based platform to automate much of the recruitment process, including engaging, selecting, and hiring job candidates.
- Mountain Technologies — Mountain Technologies is an innovative Northern Ireland-based startup that transforms mountain resort operational management.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A, Series B
- Geography: Ireland, United States
Investor stats
- Total investments: 31
- Round size: Seed $823k–$3.8M; Series A $3.1M–$12M; Series B $16M–$80M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- AYLIEN — Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs.
- Siren — Siren is a software company that provides an Investigative Intelligence platform to complex organizations and derive business value. The platform provides a unique combination of search, business intelligence, big data, link analysis and knowledge representation which advances the way organizations address some of the world’s most importantdata-driven problems.Siren makes it easier to use the data you collect to answer questions and make links, find patterns and relationships. It also uniquely enables this in real-time at a scale that companies and government organizations require. it easy to leverages and deploy data directly on backends such as Elasticsearch, relational databases, virtual data warehouses, and graph databases.Siren was awarded the Technology Innovation of the Year and Enterprise of the Year (SME) at the Information Technology Association of Galway (ITAG) Excellence Awards and also was named the Irish Startup of the Year at Ireland’s National Tech Excellence Awards.Siren was founded in 2014 and is based in Galyway, Ireland.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 91
- Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $34M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 87
- Round size: Seed $610k–$5M; Series A $5.5M–$20M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2023
Portfolio highlights
- Danalto — Simple, cost-effective, high-accuracy Location Services for large open environments, both indoor and outdoor. Asset Tracking made simple!
- MEG — MEG is a powerful end-to-end Quality Management System for healthcare. Manage quality, patient safety, compliance and accreditation processes all from one place.
- Retrograde — Retrograde is a Software Development company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $1.3M–$2.1M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more...Investment focus
- Industry: Medical Device, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 26
- Round size: Seed $878k–$3.9M; Pre-Seed $878k–$2.2M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $35M in 2019
Portfolio highlights
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- LaNua Medical — At LaNua Medical it is our mission to develop disruptive image-guided technologies providing safe and effective endovascular solutions.
- STRATxAI — STRATxAI is a WealthTech Company based in Dublin, Ireland. Specialising in AI-driven model portfolios, combining decades of expertise with proprietary AI to serve Advisors and Institutional Investors. STRATxAI Model Portfolios are built to navigate market complexity and deliver attractive risk-adjusted returns. Through close collaboration withclients, we create bespoke portfolios tailored to their unique needs, preferences and risk profiles. Alana, our proprietary engine leverages advanced machine learning algorithms to streamline the implementation and management of adaptive. multi factor strategies.
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 110
- Lead/follow: no public data
Portfolio highlights
- Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
- Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
- Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 154
- Round size: Seed $823k–$5M; Series A $2.3M–$13M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $164M in 2022
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Engage-EHS — EcoOnline's easy-to-use software system is helping companies to transform their approach to health & safety, chemical safety & learning data reporting.
- SilverCloud Health — SilverCloud Health is the trusted on-demand virtual mental health platform - Delivering proven clinical outcomes at scale. Virtual therapy and care
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 49
- Round size: Series A $6.6M–$44M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Opsona — Drug development firm focused on immunology. They are headquartered in Dublin, Ireland. Opsona Therapeutics is one of Europe's most innovative and dynamic drug development companies. We are at the forefront of drug development in immunology research, with particular focus on the innate immunity pathways. Since its founding in 2004,Opsona has validated and developed a series of exciting new drug candidates and strategies which modulate the human innate immune system. We are located in Dublin, Ireland.
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
- INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 95
- Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 110
- Round size: Seed $795k–$2.7M; Series A $1.6M–$6.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $82M in 2022
Portfolio highlights
- Kayna — Enhance your SaaS platform's value by integrating Kayna's insurance solutions. Drive additional revenue and offer more to your users with every policy sold.
- WhatClinic.com — WhatClinic.com helps patients find, compare and book the right clinics for them, in more than 135 countries. They provide detailed listings for over 120,000 clinics on their site. These include doctors, dentists, beauty and cosmetic surgery, physiotherapy, fertility, holistics and a lot more. They believe that every patient is an empoweredconsumer.
- Digit Game Studios — Founded in 2012, DIGIT is a cross-platform game developer based in Dublin, Ireland. We are the largest game developer in the country with an international team of experienced, passionate game-makers. Our first game, Kings of the Realm, was launched in September 2014 and is available on browser, iOS, Android and Windows.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Ireland, Luxembourg, The Netherlands
Investor stats
- Total investments: 30
- Round size: Seed $658k–$4.7M; Series A $2.3M–$12M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- FoodMarble — Your personal breath tester to identify food intolerances and reduce digestive symptoms. Ideal for managing IBS and SIBO, all from the comfort of home.
- HealthBeacon — Quality adherence support for your medication needs, contact our HealthBeacon team to discover what service we can provide you and your patients.
- P3 Hotel Software — P3 provides high-converting & custom booking solutions to help hotels maximise efficiency, conversion rate, and direct revenue. Integration with Oracle OPERA.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 174
- Round size: Series A $6.9M–$77M; Series B $12M–$103M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Neuros Medical — Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine.
- Simplify Medical — Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine. It offers an MRI compatible motion preserving artificial cervical disc that is used to treat single level symptomatic cervical disc disease.The company provides its products for skeletally mature patients for reconstruction of the disc at onelevel from C3-C7 following single-level discectomy for intractable radiculopathy, such as arm pain or a neurological deficit.Simplify Medical was founded in 2015 and is based in Mountain View, California.
The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, France, United Kingdom
Investor stats
- Total investments: 36
- Round size: Seed $531k–$3M; Series A $2.1M–$10M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $52M in 2021
Portfolio highlights
- BBLeap — BBLeap is a company that operates in the manufacturing industry, specifically focusing on the agricultural sector. The company's main offering is the LeapBox system, a modular solution that can be attached to any new or used sprayer. This system is designed to enhance the efficiency and effectiveness of crop spraying, addressing the issue ofover-application and weak spots in fields. BBLeap's approach, termed 'Farming On Plant Level', aims to consider individual plant needs and environmental factors such as soil conditions and weather. The company's vision is to provide better spraying equipment to the agricultural sector, contributing to more sustainable and precise farming practices.
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Boole
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $3.8M–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Incereb — Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. Founded in May 2011, Incereb is headquartered in Dublin, Ireland. The company designs and develops disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products for term and preterm infants (neonates).These intuitive products are designed to be used with minimal training and will significantly reduce the time taken to set up the neonate for EEG and CFM monitoring. Their products are designed to interface with all brands of EEG and CFM recording equipment.Incereb is an award winning early stage company that plans to invest heavily in R&D, product design and development to evolve and extend its product range. Strategic alliances with leading Irish universities and hospitals enable Incereb to leverage home-grown scientific excellence to facilitate fast commercialisation of novel devices leading to rapid growth.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Xenium Capital
Show more...Investment focus
- Industry: Medical Device, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $2.5M–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 84
- Round size: Series A $7M–$105M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Private Equity
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 268
- Lead/follow: no public data
Portfolio highlights
- Sulmara — Innovation for a sustainable energy future | Sulmara
- Besseges — ValvesTubesFittings.com launched in 2015 as the online arm of Besseges VTF and has become one of the leading online pipeline suppliers.
- Miracle Design & Play — Miracle Design & Play specializes in designing and installing playgrounds for children.
At Development Capital, they are aware of the significant growth opportunities available to mid-sized companies and understand the management teams’ unique requirement for not only finance, but also for a funding partner who will bring experience, expertise and international reach to assist secure and maximise the business growth opportunity.Development Capital provides investee companies with a unique and unprecedented partnership approach which will maximise the growth opportunity in the most prompt and efficient manner. In addition to their experienced Investment Directors, their partners include:High profile and experienced Industry Experts who will provide direction and support to investee companies; andMajor Irish Corporates who have committed not only funding but also their international experience.
Show more...Investment focus
- Industry: Manufacturing, Telecommunications, VoIP
- Stage:Seed, Private Equity
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 14
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — raised $88M in 2014
Portfolio highlights
- IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
- Nomadic Dairy — Nomadic Dairy is a growing, premium branded yogurt manufacturer. The company supplies multiple products across the UK and Republic of Ireland.
- Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 77
- Round size: Seed $1M–$9.8M; Series A $1M–$30M; Series B $7M–$45M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- 480 Biomedical — 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown,Massachusetts.
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Seed $549k–$5.5M; Pre-Seed $34k–$3.8M; Series A $3.5M–$25M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- B'ZEOS — B’ZEOS offers seaweed-based packaging solutions to industries looking for sustainable alternatives and a way to decarbonize their industry. B’ZEOS is a technology-based start-up that focuses on material development based on seaweed, and our innovation lies within the material formulation, which is converted into tailored packaging solutions.
- Ponda — Ponda is a biomaterials company pioneering regenerative-material supply chains.
- Apres — Apres is a distributed learning engine built to enable high-performance, user-friendly AI for the world.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 360
- Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Metso Outotec —
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more...Investment focus
- Industry: SaaS, Software, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Estonia, United States
Investor stats
- Total investments: 9
- Round size: Seed $642k–$1.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 86
- Lead/follow: no public data
Portfolio highlights
- FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
- Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
- Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.
Growing Capital is an early-stage investment firm specialized in supporting startups with their roots in Ireland.
Show more...Investment focus
- Industry: Software, Analytics, Health Care
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Lua Health — We believe the future of well-being is in prevention and early detection. Getting the right help, at the right time.
- Protostars — Protostars is a regulatory technology business. It is the creator of a cyber risk and compliance program meant for secure code reports on audits.
- Slick+ — Slick+ is a SaaS B2B Video-Based platform designed for enhance learning and collaboration in hybrid and remote working environment. By enabling teams to create, share, and discuss short, engaging knowledge videos, Slick+ fosters a culture of continuous learning and innovation. The platform makes it easy for employees to capture and preserveessential expertise, share best practices, and implement new ideas, all seamlessly integrated into their daily workflows. With a focus on bite-sized content, Slick+ empowers organizations to boost productivity, enhance team communication, and stay agile in a rapidly evolving work environment. Ideal for L&D and HR managers, Slick+ is the go-to solution for companies looking to optimize their onboarding, training, and knowledge-sharing processes in both hybrid and remote work setups.
Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Caju Venture Partners invests in MedTech in the European Union. Caju Venture Partners invests in entrepreneurs with high integrity who can establish great businesses and impact healthcare in the future.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
Linda Kiely is an Entrepreneur at Linda Green-Kiely Enterprises.
Show more...Investment focus
- Industry: SaaS, Software, Analytics
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Round size: Seed $1M–$1.1M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Talivest — Talivest optimises an intelligent ecosystem for hi-tech, high-growth companies by gathering insights throughout the employee lifecycle. Talivest’s solution uses machine learning and predictive analytics to help companies measure, build and maintain high performance.
- SISU Aesthetic Clinic — SISU is a collection of doctor-led, patient-centric aesthetic medical clinics.
Dan Kiely is CEO and Co-Founder of Voxpro, a premium provider of high end outsourcing services exclusively to the disruptive technology market. Dan thrives in the entrepreneurial realm. He dreams big & encourages innovation in all aspects of his company. Dan is a man of passion and creativity. Find the limit and he will smash it. Voxpro’svision has always been driven by Dan’s desire to create something unique, something unforgettable. With its 2,000+ strong work force across multiple locations in Ireland, the U.S., Romania and shortly, the Philippines, Voxpro touches the lives of hundreds of thousands of people every year, all over the world. Voxpro has a rapidly expanding geographic footprint and well considered location roll-out plan. A growing partner list includes some of the most powerful technology companies in the world. Voxpro’s partners are of great inspiration to Dan. He resonates with their entrepreneurial spirit and they, with his. Dan’s tenure at the helm continues to steer Voxpro on an exciting and successful journey. Audacious and relentless, his dreams for the company know no bounds.
Show more...Investment focus
- Industry: Software, Human Resources, Machine Learning
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 5
- Round size: Seed $240k–$1.2M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Talivest — Talivest optimises an intelligent ecosystem for hi-tech, high-growth companies by gathering insights throughout the employee lifecycle. Talivest’s solution uses machine learning and predictive analytics to help companies measure, build and maintain high performance.
- Solidroad — The Automated Quality Management platform that optimizes human and AI agents to make every customer interaction better, faster, and more consistent.
- SISU Aesthetic Clinic — SISU is a collection of doctor-led, patient-centric aesthetic medical clinics.
Liam is the founder and CEO of PCH.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: Ireland, United Kingdom, Colombia
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$7.2M; Pre-Seed $800k–$6.4M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Pandas — B2B e-commerce platform connecting Asia with the +10 million of Latin America small merchants
- Tracworx — The future of packaging is returnable and reusable. We're building the digital infrastructure to enable it.
- &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!John Purdy
Show more...Investment focus
- Industry: Software, FinTech, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 3
- Round size: Seed $576k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- dimply — The experience & engagement platform for financial enterprises.
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 755
- Round size: Seed $1.4M–$8M; Series A $6M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Paxton — Regulatory Intelligence, with the speed of Generative AI.
- Limbic — Limbic creates neuroscience of emotion packaged for developers. With just a few lines of code, anyone can make their app emotionally intelligent. Use the SDK to build products that interact with your user as naturally as interactions between two humans.
- Sharper Sense — Neuromodulation for Clear Senses
Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more...Investment focus
- Industry: Medical Device, Medical, Communities
- Stage:Series A, Private Equity
- Geography: Ireland, The Netherlands
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Sigmascreening — Pucuk138 merupakan situs andalan Slot88 official gampang gacor dengan bet 100,200 dan 500 perak Auto Maxwin dengan winrate tertinggi.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Seed, Series B
- Geography: United States, Ireland, China
Investor stats
- Total investments: 40
- Round size: Seed $1.4M–$8.2M; Series A $5M–$26M; Series B $6.5M–$69M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $2M in 2010
Portfolio highlights
- Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Myosin Therapeutics — Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD.
Glanzmann Enterprises
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 126
- Round size: Series A $5.7M–$55M; Series B $12M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Founded in 1997, Earlybird is a pan-European VC investor backing tech-enabled companies and investing in their growth and development. Funds include Earlybird, Earlybird Health, Growth Opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 328
- Round size: Seed $1.4M–$14M; Series A $4.4M–$35M; Series B $5M–$75M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $190M in 2024
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- Neuracore — Neuracore is a robot learning platform that helps to train robots and deploy intelligent behaviour.
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 127
- Round size: Series A $8.8M–$65M; Series B $15M–$120M; Series C $21M–$75M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $786M in 2023
Portfolio highlights
- Okami Medical — Okami Medical is a medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 388
- Round size: Series A $7.8M–$212M; Series B $13M–$250M; Series C $15M–$175M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
- Arbor Biotechnologies — Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Using artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, we are accelerating the discovery of proteins for improving human health and sustainability.
- Protillion Biosciences — Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Dr. Frank Dolphin is Chairman of RelateCare and founder of RigneyDolphin, a leading Irish contact center organization and parent company of RelateCare. Frank is a Chartered Psychologist by profession and has worked as a clinical and consulting psychologist at the Children’s Hospital, Temple St. and St. Joseph’s Clonmel. He has lectured at TrinityCollege Dublin and Waterford Institute of Technology in Psychology and Consumer Behavior and is a former Chairman of the Irish National Health Service Executive (HSE). Frank received Ph.D. in Psychology from University College Dublin.
Show more...Investment focus
- Industry: Hospital, Health Care
- Stage:Seed, Angel
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- PacSana — PacSana provides critical insight and understanding of user’s movement and health status. It uses a combination of sensors and expert systems to monitor critical user data and predict possible health events.
- seamlessCARE — seamlessCARE is a Digital Health Start-up. It can help people with communication difficulties due to autism, stroke, dementia, intellectual disability, and a wide range of other conditions
Health Care Investor funding in Ireland at a glance
Stats across 491 deals from 373 investors.
Access all 373 investors in Ireland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 373 investors investing in Ireland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!